BIO-Europe Spring® 2016: Accord Research on perks of business in the Czech Republic

May 10, 2016
After a couple of quiet years working on a large project, Czech Republic-based contract research organizatio Accord Research is once again playing the field and seeking new business. Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, chats with Shelia Casserly, business development director of Accord Research, during the BIO-Europe Spring partnering conference in Stockholm, Sweden, about partnerships the CRO is seeking and the company's specialist areas. She highlights Accord Research's interest in partnering with European CEOs in order to grow its business across the continent, and the benefits of business in the Czech Republic.
Previous Video
BIO-Europe Spring® 2016: Sprint Bioscience on preclinical focus and plans for long-term independence
BIO-Europe Spring® 2016: Sprint Bioscience on preclinical focus and plans for long-term independence

Anne-Marie Wenthzel, VP of business development at Sprint Bioscience, chats with Sten Stovall during the BI...

Next Video
BIO-Europe Spring® 2016: ORYX CEO on research partnerships and cancer vaccine studies
BIO-Europe Spring® 2016: ORYX CEO on research partnerships and cancer vaccine studies

Bernard Huber, CEO and founder of ORYX Translational Medicine, and Mike Ward, global director of content fo...